Sophie V. Vandebroek - 12 May 2021 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)

Role
Director
Signature
/s/ Lily J. Lu, Attorney-in-Fact for Sophie V. Vandebroek
Issuer symbol
IDXX
Transactions as of
12 May 2021
Transactions value $
$0
Form type
4
Filing time
14 May 2021, 18:04:42 UTC
Next filing
13 May 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IDXX Restricted Stock Unit Award +224 224 12 May 2021 Common Stock 224 Direct F1, F3
transaction IDXX Non-Qualified Stock Option (right-to-buy) Award +723 723 12 May 2021 Common Stock 723 $512.31 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. Restricted stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2022 annual meeting of shareholders, whichever event is earlier, and are payable as common stock on the vesting date.
F2 Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vest in one installment on the one year anniversary of the date of grant or on the date of the 2022 annual meeting of shareholders, whichever event is earlier.
F3 Not applicable.